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Abstract 
Objective: This study was conducted to find 
whether, among women without preoperative 
stress incontinence who underwent surgery for 
repair of anterior vaginal wall prolapse, the 
placement of a prophylactic midurethral mesh 
along with the prolapse correction surgery 
helped to reduce the incidence of post-operative 
stress urinary incontinence (POSUI). 
Materials & Methods: 145 women with anterior 
vaginal compartment prolapse were randomly 
assigned to receive either suitable corrective 
surgery for prolapse or corrective surgery along 
with concurrent placement of a prophylactic 
midurethral sling by a transobturator Prolene 
tape. The primary endpoint was urinary 
incontinence at three months and twelve months 
post surgery. Secondary outcomes included 
expected and unexpected adverse events. 
Results: At three months follow up the 
symptoms of urinary incontinence and/or 
positive cough test did not differ significantly 
between the two groups. But at twelve months, 
both the symptoms of urinary incontinence 
(9.59% versus 23.61%, p = 0.025, 95% CI = -
25.93% to -2.11%, CMLE OR =0.346) and 
positive cough test (8.22% versus 25%, p = 
0.007, 95% CI = -28.60% to -4.96%, CMLE OR 
= 0.271) were significantly lower in the study 
group compared to the control group. Expected 
and unexpected adverse events during 
operation and through the first year after surgery 
were comparable in both groups 
Conclusion: Placement of a midurethral sling by 
a Prolene mesh at the time of prolapse repair 
surgery significantly reduces the incidence of 
POSUI in women who were continent 
preoperatively. For this, the transobturator tape 
method is safe and effective with a low rate of 
complications. 
1Malda Medical College, Malda, West Bengal, 
India 
2Nil Ratan Sircar Medical College, Kolkata, West 
Bengal, India 
 
Introduction 
Nearly 20% of women will have the 
need to undergo an operation for pelvic 
organ prolapse (POP) in her life span.1 
Proceedings in Obstetrics and Gynecology, 2017;7(1):6 
 
Prophylactic midurethral sling  2 
 
Another common problem among 
women is lower urinary tract 
abnormalities including incontinence 
which is common in women with high 
grade anterior compartment prolapse. 
Stress urinary incontinence (SUI) is 
characterized by involuntary passage of 
urine when the intravesical pressure 
rises higher than the pressure that the 
urethral closure mechanism can 
withstand, for example during coughing 
or sneezing. It is one of the most 
common causes of incontinence in 
women, with a peak incidence between 
45 and 49 years of age.2 Risk factors for 
the development of stress urinary 
incontinence include childbirth; 
especially when the deliveries are by 
vaginal route compared to that of 
cesarean section.3 
Vaginal birth also predisposes a woman 
to develop pelvic organ prolapse. It is 
unsurprising therefore, that the two 
conditions frequently co-exist. The basic 
pathophysiology of both conditions is 
the same; laxity of support structures 
leads to loss of urethral resistance in 
one and prolapse in the other. It was 
found that previously continent women, 
who underwent a repair operation for 
anterior compartment prolapse such as 
cystocele and/or urethrocele, were at 
increased risk of emergent post-
operative stress urinary incontinence 
(POSUI). Several studies have reported 
that the incidence of POSUI varies from 
11% to 47%.4-7 Stress urinary 
incontinence, symptomatic or occult, 
which was absent preoperatively, may 
occur following anterior wall repair. No 
method is 100% accurate in detecting 
occult SUI and/or predicting 
development of post-operative SUI in 
women with POP.8-10 Simple clinical 
tests (such as, repositioning the 
prolapse using a pessary and a 
Pyridium pad test11 or a one-week 
ambulatory home pessary trial12) can be 
used to find out if occult urinary 
incontinence exists or not. As a 
measure against this unwanted 
complication i.e. POSUI, studies are 
being carried out on the effectiveness of 
a concomitant procedure along with the 
primary corrective surgery for POP. 
However, some authors advocate 
placement of a suburethral sling by 
systematic approach, taking into 
account the patients' variables and their 
own goals of therapy.13-16 Several 
studies have been conducted to assess 
the benefits and effects of a prophylactic 
sling surgery. Various studies have 
evaluated this in the context of 
abdominal surgery, for example, Burch 
colposuspension7,8 and vaginal 
procedures, such as, transvaginal 
tape18-21 and transobturator tape22 
approach. To the best of our knowledge, 
no such study has been conducted in 
India. This study evaluates the benefits 
and side effects of prophylactic 
midurethral sling placement during 
repair of anterior compartment prolapse. 
Aims and objectives 
This study aimed to find whether, 
placement of a prophylactic midurethral 
sling helped to reduce the incidence of 
post-operative stress urinary 
incontinence (POSUI) in women without 
pre-operative stress incontinence of any 
kind (occult or overt) who underwent 
surgery for repair of anterior vaginal wall 
prolapse. 
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Materials and methods 
This prospective randomized 
comparative trial (RCT) was carried out 
between January, 2013 and December, 
2014, at a urogynecology referral center 
in Kolkata, India. One hundred and sixty 
six women who attended our Out 
Patients Department with signs and 
symptoms of anterior vaginal 
compartment prolapse (Stage II or 
greater cystocele), were scheduled for 
corrective surgery and fulfilled the 
eligibility criteria were assessed for 
enrolment in the study. Women who 
fulfilled the eligibility criteria on the basis 
of the interview and clinical examination 
(examined by resident doctors under the 
supervision of the consultant-in-charge) 
were counseled in the simplest 
language of their understanding, about 
the nature of the illness and the surgical 
procedure according to United States 
Food and Drug Administration (U.S. 
FDA) guidelines.23 The additional sling 
procedure along with the benefits as 
well as adverse effects were explained. 
Written informed consents were 
obtained from willing participants. 
After undergoing thorough exclusion 
criteria 145 women were included in the 
study. Exclusion criteria were (a) 
symptomatic stress urinary 
incontinence, (b) positive cough stress 
test on admission, (c) contraindication 
for mid-urethral sling, such as, prior 
urethral/bladder neck operation, (d) 
women planning pregnancy within one 
year after operation, (e) medical illness 
requiring hospitalization on two or more 
occasions during the last one year, (f) 
previous surgery for POP, (g) post 
hysterectomy POP and (h) 
unwillingness to participate. The control 
group was assigned to receive the 
corrective surgery for prolapse while the 
sling group received the primary 
corrective surgery along with concurrent 
placement of a prophylactic midurethral 
sling by transobturator tape (TOT). A 
computer-generated randomization 
protocol divided the participants into two 
groups having 73 women in the study 
group (group A) and 72 in the control 
group (group B). The treatment 
allocation was concealed in opaque 
sequentially numbered envelopes which 
were deposited at the operation theatre 
and the surgeons doing the operations 
collected the corresponding sealed 
envelope directly from the operation 
theatre sister-in-charge just before 
performing the operation and the 
procedure was completed as per code. 
The control group was assigned to 
receive the suitable corrective surgery 
for prolapse while the sling group 
received the primary corrective surgery 
along with concurrent placement of a 
prophylactic midurethral sling by 
transobturator tape. To avoid surgical 
bias as much as possible, all the 
procedures (sling and control group) 
were carried out by five members of a 
single surgical team. All surgeries were 
performed under spinal anesthesia. 
Standard technique for anterior 
colporrhaphy was performed with two 
layer repair of endopelvic fascial defect. 
Posterior defects were repaired in two 
layers and included repair of relaxed 
perineal body and rectocele. The 
patients who were assigned to receive 
the prophylactic midurethral sling (sling 
group) underwent TOT procedure with a 
Prolene mesh of size 9 x 1.5 cms with 
center measuring 2 cms wide x 2.5 cms 
across, placed over the mid portion of 
the urethra. Intra-operative difficulties 
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and complications were noted and 
recorded. The post-operative course of 
all patients was assessed and recorded. 
The urinary catheter was removed for all 
patients after 24-28 hours. All patients 
who did not have any post-operative 
complications were discharged on post-
operative day five. 
The primary end point of the study was 
stress urinary incontinence which was 
identified by a positive cough stress test, 
symptoms of or treatment for urinary 
incontinence, at three and twelve 
months. Secondary outcomes included 
serious adverse events, expected 
complications typical of Prolene mesh 
and unexpected non-serious adverse 
events. 
According to the outcomes following 
vaginal prolapse repair and midurethral 
sling trial,18 the incidence of post-
operative stress urinary incontinence in 
women who were not given a 
prophylactic midurethral sling was 43% 
(compared to 18% in the other group) at 
12 months follow up. This 25% 
difference in the incidence of 
postoperative stress urinary 
incontinence between the concomitant 
prophylactic midurethral sling group and 
the control group (18% vs. 43%), was 
used to calculate the sample size for our 
study. The minimum sample size was 
calculated as 122, with 61 subjects in 
each arm, setting alpha error at 0.05 
with a power of 80, based on standard 
estimate with continuity correction 
(Fleiss, Statistical methods for Rates 
and Proportions). Before analyses a 
self-regulating second researcher 
double checked all data which was 
subsequently analyzed using Open 
Source Epidemiologic Statistics for 
Public Health (Dean AG, Sullivan KM, 
Soe MM. OpenEpi: Open Source 
Epidemiologic Statistics for Public 
Health, www.OpenEpi.com, version 
3.03, updated on 2014/09/22). The 
statistical calculations included 
independent “t” tests, mid-p exact tests, 
and conditional maximum likelihood 
estimate of odds ratio with confidence 
limits. The study was approved by the 
Institutional Ethical Committee as 
required by Indian law. 
Results 
One hundred sixty six women were 
assessed initially for eligibility criteria. Of 
these, 21 women were excluded from 
the study due to, either not fulfilling the 
criteria for inclusion (n= 13) or refusal for 
participation (n= 08). Randomization 
was done with 145 patients placed into 
two groups having 73 in the study group 
(Group A) and 72 in the control group 
(Group B). The control group was 
assigned to receive the corrective 
surgery for prolapse while the sling 
group received the primary corrective 
surgery along with concurrent 
placement of a prophylactic midurethral 
sling by a transobturator tape. 
Subsequently, 12 patients were lost 
during follow up post operatively (five 
from study group and seven from the 
control group). As we adopted the 
intention to treat principle for trial 
analysis, all patients were analyzed 
according to allocation treatment (Figure 
1). Participants who were missing 
components of the compound end point 
were assumed to have had symptoms of 
incontinence and positive cough test. 
Demographically, the patients in both 
groups were comparable in respect to 
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age, parity, body mass index, 
socioeconomic and educational 
standard, menstrual status and grade of 
cystocele (Table 1). From Table 2, it is 
evident that the types of surgical 
procedures for POP in the two groups 
were comparable.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Patients’ flow through chart 
Assessed for eligibility (n=166) 
Randomized (n=145) 
Excluded (n=21) 
Not meeting inclusion criteria (n=13) 
Refused to participate (n=8) 
Enrollment 
Allocated to under prolapse surgery + 
prophylactic sling (n=73) 
Received allocated intervention 
(n=73) 
Did not receive allocated intervention 
(n=0) 
Allocated to undergo prolapse surgery 
alone (n=72) 
Received allocated intervention (n=72) 
Did not received allocated intervention 
(n=0) 
Follow-up 
Lost to follow-up 
3 months (n=0) 
12 months (n=5) 
Allocation 
Lost to follow-up 
3 months (n=0) 
12 months (n=7) 
Analysis 
Analyzed (n=73) 
Excluded from analysis (n=0) 
Analyzed (n=72) 
Excluded from analysis (n=0) 
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Table 1: Demographic profile 
Characteristics Study group Control group P value 
    
 (n=73) (n=72) (95% CI of difference) 
    
Age in years  (mean ± sd#) 53.86 ± 8.91 55.75 ± 9.36 0.2151(-4.889 to 1.109) 
    
Body mass index 22.19±1.62 22.08±1.53 0.6751(-0.407 to 0.627) 
    
Parity    
    Para 1 to 3 51 (69.86%) 52 (72.22%) 0.7582(-12.40 to 17.1) 
   Para 4 or more 22 (30.14%) 20(27.78%)  
    
Socio-economic status    
    Above poverty line 12 (16.44%) 10 (13.89%) 0.6782(-9.116 to 14.210) 
     Below poverty line      61 (83.56%) 62 (86.11%)  
    
 Educational Status    
      Illiterate 15 (20.55%) 17 (23.61%) 0.6632 
      Primary school 39 (53.42%) 41 (56.94%) 0.6742 
      Secondary school 15 (20.55%) 12 (16.67%) 0.5582 
      Higher education   4 (5.48%) 2 (2.78%) 0.4552 
    
Menstrual status    
      Premenopausal  15 (20.55%) 15 (20.55%) 0.5582 (-8.77 to 16.53) 
      Postmenopausal  58 (35.62%) 60 (83.33%)  
    
Grade of cystocele    
      Grade II 47(64.38%) 44(61.11%) 0.6882 
      Grade III 26(35.63%) 28(38.89%) (-12.46 to 19.00) 
    
  # Standard deviation.      1 p-value (two-tailed).       2 Mid-P exact.   
 
While symptoms of urinary incontinence, 
positive cough test and treatment for 
incontinence were greater in the control 
group than those in the study 
(prophylactic TOT) group at three 
months, the figures were not statistically 
significant (Table 3). However both 
symptoms of urinary incontinence 
(9.59% versus 23.61%, p = 0.025, 95% 
CI = -25.93% to -2.11%, CMLE OR 
=0.346) and positive cough test (8.22% 
versus 25%, p = 0.007, 95% CI = -
28.60% to -4.96%, CMLE OR = 0.271) 
were significantly lower at 12 months in 
the study group. Expected and 
unexpected adverse events (secondary 
outcomes) during operation and through 
the first year after surgery were 
comparable in both groups. Three 
women in the study group needed 
urethral dilation for post-operative 
voiding difficulty and one woman had 
mesh erosion, the numbers were 
statistically insignificant (Table 4). 
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Table 2: Surgical procedures performed for POP. 
Type of operation Study group Control group P value* 
 (n=73) (n=72) (95% CI) 
    
Anterior colporrhaphy 04 (5.48%) 05 (6.94%) 0.731 (-9.322 to 6.392) 
    
Vaginal hysterectomy + anterior colporrhaphy 34 (46.57%) 29 (40.28%) 0.451 (-9.804 to 22.40) 
         
Anterior colporrhaphy + colpoperineorrhaphy 09 (12.33%) 07 (9.72%) 0.630 (-7.577 to 12.79) 
        
Vaginal hysterectomy + anterior colporrhaphy+ 26 (35.62%) 31 (43.06%) 0.366 (-23.30 to 8.418) 
      Colpoperineorrhaphy    
* Mid-P exact 
 
Discussion 
With the life expectancy of women in 
India having risen to 68.5 years,24 it is 
natural to expect that we would be 
facing more patients with complaints of 
pelvic organ prolapse and stress urinary 
incontinence. Moreover, previously 
continent women who undergo surgical 
repair of anterior compartment prolapse 
may be at increased risk of developing 
post-operative stress urinary 
incontinence (POSUI). Thus, it has been 
suggested that a concomitant procedure 
may be added along with the primary 
corrective surgery of anterior 
compartment prolapse for prevention of 
post-operative stress incontinence. This 
prophylactic procedure, a transobturator 
synthetic mesh placement, was adopted 
in 73 women with various types of 
surgeries for POP in our RCT with a 
control group of 72 women. 
The average age of the women in our 
study, 53.86 ± 8.91 years for the study 
group and 55.75 ± 9.36 years for the 
control group, was lower compared to 
that in the study by Wei et al.,18 63.4± 
10.8 in the sling group and 62.2±10.2 in 
the control group. Our study also had a 
very different profile in terms of 
socioeconomic status with 83.56% of 
cases and 86.11% of controls being 
below the poverty line compared to 
western studies. Similarly, educational 
status of the women in our study 
differed significantly from that in the 
study by Wei et al.18 While their study 
had 37% and 44% women completing 
high school or less in the sling and 
control group respectively, our study 
had 21.03% (in study group) and 
19.45% (in control group) women having 
post primary education. In our study, 
there were no patients with stage 4 
cystocele. This was in contrast to the 
study by Wei et al.18 where 08% and 
10% of the sling and the control group 
had Stage 4 cystocele and by Brubaker 
et al.7,8 where 21% of the Burch group 
and 17% of the control group had stage 
4 cystocele. 
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Table 3: Primary outcomes at three and twelve months follow-up. 
Outcome  Study group Control group P Value # OR* 
 (n=73) (n=72) ( 95% CI ) (  95% CI ) 
     
End point at three months 
   (12 to14 weeks) 
    
 Symptoms of incontinence 1 (1.37%) 5 (6.94%) 0.115 
(-12.02% to 0.87%) 
0.188 
(0.008 to 1.40) 
          
Positive cough test 0 3 (4.17%) 0.120 
(-8.78% to 0.45%) 
0.0 (0.0 to 1.67) 
     
Treatment for incontinence 1 (1.37%) 5 (6.94%) 0.115 
(-12.02% to 0.87%) 
0.188 
(0.008 to 1.40) 
     
End point at twelve months:     
A. ITT analysis1     
    Symptoms of incontinence   2+5♦ (9.59%) 10+7♦ (23.61%) 0.025 
(-25.93% to -2.11%) 
0.346 
(0.125 to 0.881) 
      
    Positive cough test 1+5♦ (8.22%) 11+7♦ (25%) 0.007 
(-28.60% to -4.96%) 
0.271 
(0.093 to0.713) 
     
B. PP analysis2     
     
    Symptoms of incontinence  2/68 (2.94%) 10/65 (15.38%) 0.014 
(-22.09% to -2.80%) 
0.169 
(0.024 to 0.727) 
     
    Positive cough test 1/68 (1.47%) 11/65 (16.92%) 0.002 
(-25.01% to -5.90%) 
0.074 
(0.003 to 0.456) 
# Mid-P exact.       * Conditional maximum likelihood estimate of Odds Ratio. 
1Intention to treat principle.   2Per protocol.     ♦ Lost to follow up cases. 
 
 
In view of varying degrees of uterine 
prolapse and due to most patients 
wishing against retention of their uterus, 
the majority of the women in our study 
underwent hysterectomy along with the 
prolapse repair; 82.19% in the sling 
group and 83.34% in the control group 
respectively. In the study by Wei et al.,18 
however, only 50% and 48% of the sling 
and the control group underwent 
concomitant hysterectomy respectively. 
Additionally 38% of the women from 
both groups in their study had had 
previous hysterectomy. In our study, 
47.95% of the women in the sling group 
and 52.78% in the control group had 
repair of posterior compartment 
prolapse also, which was similar to the 
study by Wei et al.18 where 45% and 
47% of women from the sling and 
control group respectively underwent 
posterior repair additionally. 
The study conducted by Brubaker et 
al.7,8 evaluated abdominal 
sacrocolpopexy with additional Burch 
colposuspension for urethral support. 
The study conducted by Wei et al.18 
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evaluated the same while using 
transvaginal tape (TVT) for midurethral 
support. This was similar to the 
procedure evaluated by Meschia et al.21 
and Gordan D et al.20 In our study we 
utilized the transobturator polypropylene 
mesh as midurethral sling. This 
technique of sling placement was similar 
to the procedure undertaken by Araki et 
al.22 who performed transobturator 
midurethral sling placement only in 
patients with symptomatic SUI and/or 
positive cough test along with repair of 
POP by polypropylene mesh. 
Table 4: Expected and unexpected adverse events during operation and through 
first year after surgery. 
 
Outcome      Study 
group 
Control 
group 
P Value # CMLE OR* 
 (n=73) (n=72) ( 95% CI ) (  95% CI ) 
     
Major bleeding or vascular 
complication 
2 (2.74%) 4 (5.56%) 0.435  
(-9.30% to3.67%) 
0.481  
(0.06 to 2.80) 
     
Urethral or bladder injury 2 (2.74%) 1 (1.39%) 0.630  
(-3.27 % to 5.97%) 
1.99 
 (0.15 to 59.77) 
     
Operative site infection 1 (1.37%) 1 (1.39) 0.993  
(-3.82 % to 3.78%) 
0.986  
(0.02 to 38.97) 
     
Urinary tract infection 2 (2.74%) 3 (4.17%) 0.672  
(-7.37% to 4.52%) 
0.6498  
(0.07 to 4.49) 
     
Post-operative urinary retention 
following catheter removal 
6 (8.22%) 7 (9.72%) 0.7619  
(-10.8% to 7.80%) 
0.833 
(0.25 to 2.70) 
     
Incomplete bladder emptying 3 (4.11%) 1 (1.39%) 0.377 
(-2.57% to 8.02%) 
3.02 
 (0.31 to 81.16) 
     
Postoperative voiding difficulty 
requiring urethral dilatation+ 
3/68 
(4.41%) 
0/65 0.131  
(-0.47% to 9.29%) 
undefined 
     
Mesh erosion+ 1/68 
(1.47%) 
0/65 0.511  
(-1.39% to 4.33%) 
undefined 
     
* Conditional maximum likelihood estimate of Odds Ratio.       # Mid-P exact     
+ Per protocol analysis was done considering the nature of complication. 
 
In our study, 6.94% of the patients who 
did not undergo the additional 
midurethral sling placement developed 
POSUI at three months following 
surgery in comparison to only 1.37% of 
those who underwent concomitant 
prophylactic midurethral sling 
placement. However, this difference was 
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not statistically significant This was in 
contrast to the findings of Wei et al.18 
who reported a urinary incontinence rate 
of 23.6% in the sling group and 49.4% in 
the sham group (adjusted odds ratio, 
95% CI, 0.19 to 0.50; p<0.001). The trial 
by Brubaker et al.7,8 also showed a 
significant difference with 23.8% (35 
women) of the Burch group and 44.1% 
(67 women) of the control group 
meeting one or more criteria for stress 
incontinence (P<0.001). This difference 
at 3 months between our study and their 
study could have been due to the higher 
stage of pelvic organ prolapse in the 
above studies compared to ours. 
Presence of incontinence and/or 
positive cough test at 12 months 
following surgery in the group of women 
with prophylactic concomitant TOT 
placement were significantly lower 
compared to those in control group. The 
results of our study were similar to those 
found by Wei et al.18 who also reported 
a significant difference of SUI at 12 
months post surgery (p <0.001). 
Brubaker et al.7,8 also showed that at 12 
months, women who had an additional 
Burch colposuspension along with 
abdominal sacrocolpopexy had 
significantly lower rates of urinary 
incontinence (p = 0.02). 
No patient in either group of our study 
had any serious adverse event during 
the surgery. The study conducted by 
Wei et al.18 reported similar outcome. 
Our study reported no difference in the 
rates of major bleeding and vascular 
complications (p=0.435). In contrast, 
Wei et al.18 had a significantly higher 
rate of bleeding complications in the 
sling group (p=0.03). Only two patients 
from our study had urethral or bladder 
injury during sling placement. Kuan-Hui 
Huang et al.25 in their study did not 
report any bladder injury or other 
complications that required laparotomy 
during concomitant TVT procedure 
along with primary surgery for pelvic 
organ prolapse. This was in contrast to 
Wei et al.18 who had a significant 
number of patients from the sling group 
with this complication. Their study 
utilized the transvaginal mesh in 
contrast to transobturator mesh which 
has a higher bladder perforation rate as 
reported by other authors.13-16 
Our study did not report any significant 
difference between the two groups for 
incidence of urinary tract infection 
(p=0.672). This was in contrast to the 
findings of the OPUS trial18 where the 
difference was significant (p=0.008). 
The same trial also reported a 
significant incidence of incomplete 
bladder emptying (p=0.01) in the sling 
group which was found only in three 
patients in our study (p=0.377). None of 
the patients in our study required 
urethrolysis surgery in contrast to the 
findings of Wei et al.18 who did 
urethrolysis for persistent voiding 
dysfunction in sling group (4/165 versus 
0/172, p = 0.06). One patient from our 
sling group developed mesh erosion 
(1.47%) and was successfully treated by 
excision of the eroded tape and repair of 
anterior vaginal wall in two layers. In the 
study conducted by Wei et al.18 no 
patient developed mesh erosion. Groutz 
et al.26 reported 3% incidence of erosion 
of the vaginal tape for treatment of 
occult stress urinary incontinence. 
Our study had the limitation of only 145 
subjects as the total duration of study 
was 24 months. While sample size 
calculations were performed and 
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confirmed the number needed for each 
group, a larger sample size may give 
more significant results. Routine pre-
operative urodynamics for occult SUI 
was not performed on our patients. Our 
study did not assess pre and post-
operative quality of life such as by pelvic 
floor distress questionnaires, etc. Also, 
our patients were followed up only for 
one year following the surgery. 
To conclude, the placement of a 
midurethral Prolene mesh concomitantly 
during repair of anterior compartment 
prolapse significantly reduces the 
incidence of post-operative stress 
urinary incontinence in women who 
were continent preoperatively. For this, 
the transobturator tape method is safe 
and effective with a low rate of 
complications. Concomitant placement 
of a midurethral sling may prevent the 
need for a woman to undergo a second 
surgical procedure following the primary 
prolapse repair. More studies with larger 
sample sizes are required to evaluate 
for the long term efficacy and safety of 
prophylactic concomitant mesh 
placement in the mid portion of urethra 
during surgery for POP. 
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